Centre clarifies Chhattisgarh govt's concerns over COVAXIN expiry date: 'Unfounded claims'

Refuting Chhattisgarh health minister T S Singh Deo's 'concerns' over COVAXIN, Union Health Minister Dr. Harsh Vardhan on Thursday assured that Bharat Biotech-ICMR vaccine was granted permission to manufacture by CDSCO following due procedure and evaluation. He added that only Covaxin and Covishield were being used for vaccination drive throughout country. Terming Deo's concerns regarding unavailability of expiry date on Covaxin trial as 'unfounded', he said that same is mentioned on label of vaccine vials.

Priyanka Gandhi takes a dip in Ganga on 'Mauni Amavasya'; goes temple-hopping in Prayagraj

Centre to Chhattisgarh: 'Concerns unfounded'

MP CM clarifies on death of man 10 days after COVAXIN trial, terms it as a ‘misconception'

Chhattisgarh min: 'Covaxin must t be allowed'

On 10 January, Deo said use of COVID-19 vaccine `Covaxin' must t be allowed in state as its third-st clinical trial data has t been published yet. Stating that he was t "confident" about asking people to take this vaccine, he added  'Its use should be avoided until its complete results are out'. As of date, share of Covaxinis less than 11 percent of over 2 crore vaccine doses supplied to states so far, as per govt data.

"On January 3, our experts and government had kept fact this infront of us that Covaxin's phase 3 trial is t completed. y guessed safety of trial only from phase 1 and 2 trials and said that its immugenicity has been proven, refore this has been proved from emergency use. refore, use of words 'emergency use' gets a little confusing here. That is why it is my opinion that untill final results of vaccine are out, it should be stopped from us," he said.

Chhattisgarh Health Minister says COVAXIN Covid vaccine shouldn't be allowed in state

DCGI gives d to COVISHIELD & COVAXIN

On January 3, Drug Controller General of India (DCGI) VG Somani anunced that vaccines of Serum Institue of India (Covishield) and Bharat Biotech (Covaxin) have been granted permission for restricted use in an emergency situation. Covishield - a Recombinant Chimpanzee Adevirus vector vaccine - has an efficacy of 70.42%, with interim safety and immugenicity data of Phase-II/III trials submitted to SEC. Covaxin - a Whole Virion Inactivated Corona Virus Vaccine - 22,500 participants vaccinated in Phase-III trials and was found to be safe as per data available till date. After a day of heavy politicisation over vaccines and ir approvals, two manufacturers - Serum Institute of India & Bharat Biotech issued a joint statement pledging global access to ir vaccines. As of date, 70,17,114 vaccine doses have been administered.

LAC disengment begins from south Pangong Tso area after Indo-China agreement, video out